Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease.

scientific article published on 6 March 2017

Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JACI.2016.11.023
P932PMC publication ID5496786
P698PubMed publication ID28279492

P50authorTaylor A DohertyQ38325230
Bruce L ZurawQ56663848
P2093author name stringDavid H Broide
Andrew A White
Sandra C Christiansen
Maya R Karta
Alex S Kim
Jacqueline J Eastman
Kellen J Cavagnero
Adam S Deconde
P2860cites workCutting edge: agonistic effect of indomethacin on a prostaglandin D2 receptor, CRTH2Q28166254
A controlled study of 9α,11β-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challengeQ28195706
Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory diseaseQ30276354
Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced AsthmaQ33921113
Enhanced innate type 2 immune response in peripheral blood from patients with asthmaQ34111924
Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literatureQ34441715
Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsivenessQ34624361
Prostaglandin D₂: a dominant mediator of aspirin-exacerbated respiratory diseaseQ34892917
At the bench: understanding group 2 innate lymphoid cells in disease.Q35115465
Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity.Q35634065
IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungsQ35685426
Group 2 innate lymphocytes (ILC2) are enriched in active eosinophilic esophagitisQ36037301
Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation PathwayQ36119388
Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity.Q36157993
TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammationQ36798825
Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine productionQ36991150
Chronic Rhinosinusitis with Nasal PolypsQ37080775
Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitisQ37138334
Th9 and allergic diseaseQ37552040
Prostaglandin D2 regulates human type 2 innate lymphoid cell chemotaxis.Q37619448
Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cellsQ37691114
Innate and adaptive immune responses in asthmaQ38007827
Aspirin-intolerant asthma (AIA) assessment using the urinary biomarkers, leukotriene E4 (LTE4) and prostaglandin D2 (PGD2) metabolitesQ38013046
Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory diseaseQ41146048
Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory diseaseQ42950579
Mediators of inflammation in nasal lavage from aspirin intolerant patients after aspirin challengeQ43069043
Inhaled leukotriene E(4), but not leukotriene D(4), increased airway inflammatory cells in subjects with atopic asthmaQ43796672
Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmaticsQ44675978
Comparison of specific gravity and creatinine for normalizing urinary reproductive hormone concentrationsQ44856833
Human T(H)2 cells respond to cysteinyl leukotrienes through selective expression of cysteinyl leukotriene receptor 1.Q44891908
Aspirin-induced asthma. Hypersensitivity to fenoprofen and ibuprofen in relation to their inhibitory action on prostaglandin generation by different microsomal enzymic preparationsQ48379723
Omalizumab in the treatment of aspirin-exacerbated respiratory disease.Q51661831
IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs.Q53793238
Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstrictionQ69304770
Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthmaQ72964940
Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cellsQ80736011
Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161Q84933191
Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapyQ85294417
Type 2 innate lymphoid cells in induced sputum from children with severe asthmaQ85908714
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectaspirinQ18216
P304page(s)101-108.e3
P577publication date2017-03-06
P1433published inThe Journal of Allergy and Clinical ImmunologyQ7743550
P1476titleGroup 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease
P478volume140

Reverse relations

cites work (P2860)
Q38739370Advanced Role of Neutrophils in Common Respiratory Diseases
Q93352014Airway innate lymphoid cells in the induction and regulation of allergy
Q64083734Aspirin Exacerbated Respiratory Disease: Epidemiology, Pathophysiology, and Management
Q89098605Cytokine and Lipid Mediator Regulation of Group 2 Innate Lymphoid Cells (ILC2s) in Human Allergic Airway Disease
Q48204581Cytometric Gating Stringency Impacts Studies of Type 2 Innate Lymphoid Cells in Asthma.
Q47719552Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implications.
Q95840967ILC2 Lung-Homing in Cystic Fibrosis Patients: Functional Involvement of CCR6 and Impact on Respiratory Failure
Q92100352Increased expression of type 2 innate lymphoid cells in pediatric patients with allergic rhinitis
Q64255314Innate Lymphoid Cells in Mucosal Immunity
Q49980468Innate lymphoid cells and allergic disease
Q38699307Leukotriene C4 Potentiates IL-33-Induced Group 2 Innate Lymphoid Cell Activation and Lung Inflammation
Q55192190Lipid regulation of group 2 innate lymphoid cell function: Moving beyond epithelial cytokines.
Q99575721Lipid-mediated innate lymphoid cell recruitment and activation in AERD
Q90330860NSAID-ERD Syndrome: the New Hope from Prevention, Early Diagnosis, and New Therapeutic Targets
Q90108933Omalizumab for Aspirin-Hypersensitivity and Leukotriene Overproduction in Aspirin-Exacerbated Respiratory Disease: A Randomized Trial
Q90271537Prostaglandin E2 in NSAID-exacerbated respiratory disease: protection against cysteinyl leukotrienes and group 2 innate lymphoid cells
Q58086903Prostaglandin-cytokine crosstalk in chronic inflammation
Q97521492Regulation of Human Innate Lymphoid Cells in the Context of Mucosal Inflammation
Q90884836Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps
Q47656375Role of group 2 innate lymphocytes in aspirin-exacerbated respiratory disease pathogenesis
Q90393410The Biology of Prostaglandins and Their Role as a Target for Allergic Airway Disease Therapy
Q48093883The role of basophils as innate immune regulatory cells in allergy and immunotherapy

Search more.